Elastic shares jump 22% after first-quarter results, raised guidance
Elastic shares rose 21.8% in pre-market trading after the company reported better-than-expected first-quarter adjusted earnings and sales, then raised FY27 guidance.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Quoin Pharmaceuticals reports positive interim Phase 2/3 data for QRX003
Quoin Pharmaceuticals reported positive interim data from its ongoing Phase 2/3 study of QRX003 in Netherton syndrome.
QNRX - Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome
QNRX - Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome